“What Karius is good at is identifying those novel microbes before they become an outbreak like coronavirus,” says Mickey Kertesz, a chief executive whose life sciences startup just hauled in $165 million in new funding. While the new money may have been raised under the looming threat of Covid 19, the company’s technology is already […]...